1. Home
  2. GDYN vs VALN Comparison

GDYN vs VALN Comparison

Compare GDYN & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grid Dynamics Holdings Inc.

GDYN

Grid Dynamics Holdings Inc.

HOLD

Current Price

$5.68

Market Cap

509.3M

Sector

Technology

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.36

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDYN
VALN
Founded
2006
2012
Country
United States
France
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
509.3M
536.9M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
GDYN
VALN
Price
$5.68
$5.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$10.67
$15.50
AVG Volume (30 Days)
1.9M
26.0K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
120.00
N/A
EPS
N/A
N/A
Revenue
$111,283,000.00
N/A
Revenue This Year
$10.16
N/A
Revenue Next Year
$10.84
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.13
$5.06
52 Week High
$12.86
$12.25

Technical Indicators

Market Signals
Indicator
GDYN
VALN
Relative Strength Index (RSI) 35.66 40.34
Support Level $5.27 $5.11
Resistance Level $6.11 $6.69
Average True Range (ATR) 0.48 0.19
MACD -0.14 -0.01
Stochastic Oscillator 2.47 25.53

Price Performance

Historical Comparison
GDYN
VALN

About GDYN Grid Dynamics Holdings Inc.

Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: